Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.
Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir...
On Friday April 24th, 2020 ANEA hosted a virtual gathering for HIV/AIDS community organizations and leaders involved in "Ending the Epidemic" state, local, or community initiatives that are experiencing disruptions from the COVID-19 pandemic.
This policy brief discusses the impact of underfunding TB research led by U.S. government agencies. The brief explores several prospective opportunities for TB R&D that would be made possible with increased funding, with recommendations on where policymakers and appropriators can make key investments to U.S. government agencies to advance crucial science on TB diagnostics, treatments, and vaccines.
The ACT NOW:END AIDS Coalition, of which TAG is a founding member, released this statement today calling for the administration’s efforts to end the HIV epidemic to be rooted in fact, science, and sensible policies that are consistent with the stated goal of ending HIV.
TAG, as part of the Save NY Public Health Campaign, called out Governor Cuomo's recently announced Medicaid cuts and other failures to adequately address health and health equity in his January 8, 2020 "State of the State" address.
Treatment Action Group (TAG) applauds progress in New York towards ending HIV as an epidemic, with record decreases in estimated statewide and citywide HIV incidence in 2018. TAG states that accelerating impact at the community level will be critical to reach the Ending the Epidemic 2020 targets.
In honor of World AIDS Day, Treatment Action Group (TAG) continues to stand with the global harm reduction movement in support of evidence based, live saving interventions for people who use drugs, including syringe service programs and safer consumption spaces (SCS).
Treatment Action Group (TAG) welcomes the U.S. Department of Health and Human Services (HHS) pursuit of a lawsuit against Gilead Sciences, Inc., the manufacturer of Truvada and Descovy, the only two FDA-approved pills for pre-exposure prophlyaxis (PrEP) to prevent HIV.
Treatment Action Group (TAG) is honored that acclaimed American Artist Glenn Ligon has created and donated a Limited Art Edition entitled Black Rage (back cover) in an edition of 100 prints (and 20 A/Ps) especially for TAG.